A Win For Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. (CYTO:NASDAQ) soared at $1.11, representing a gain of 29.8%. On Thu, May 04, 2023, CYTO:NASDAQ hit a New 2-Week High of $1.11. The stock appeared on our News Catalysts scanner on Mon, May 01, 2023 at 09:25 AM in the 'MISCELLANEOUS' category. From Thu, Apr 20, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Thu, May 04, 2023 at $1.42 with a volume of 32M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Soligenix, Inc. (SNGX:NASDAQ), 60.56%
- Inseego Corp. (INSG:NASDAQ), 52.66%
- SigmaTron International, Inc. (SGMA:NASDAQ), 47.06%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 38.26%
- SRAX, Inc. (SRAX:NASDAQ), 37.5%
- NANO-X IMAGING LTD (NNOX:NASDAQ), 34.96%
- GlucoTrack Inc. (GCTK:NASDAQ), 34.32%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 31.63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 29.81%
- MDJM Ltd. (MDJH:NASDAQ), 28.5%